3D Bioprinting Market Size, Share, and Trends 2024 to 2034

The global 3D bioprinting market size is calculated at USD 3.55 billion in 2025 and is forecasted to reach around USD 13.05 billion by 2034, accelerating at a CAGR of 15.84% from 2025 to 2034. The North America 3D bioprinting market size surpassed USD 0.99 billion in 2024 and is expanding at a CAGR of 16.01% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : January 2025
  • Report Code : 2107
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on 3D Bioprinting Market 

5.1. COVID-19 Landscape: 3D Bioprinting Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global 3D Bioprinting Market, By Component

8.1. 3D Bioprinting Market, by Component,

8.1.1. 3D Bioprinters

8.1.1.1. Market Revenue and Forecast

8.1.2. Bioinks

8.1.2.1. Market Revenue and Forecast

Chapter 9. Global 3D Bioprinting Market, By Technology

9.1. 3D Bioprinting Market, by Technology,

9.1.1. Magnetic Levitation

9.1.1.1. Market Revenue and Forecast

9.1.2. Inkjet-based

9.1.2.1. Market Revenue and Forecast

9.1.3. Syringe-based

9.1.3.1. Market Revenue and Forecast

9.1.4. Laser-based

9.1.4.1. Market Revenue and Forecast

9.1.5. Others

9.1.5.1. Market Revenue and Forecast

Chapter 10. Global 3D Bioprinting Market, By Application 

10.1. 3D Bioprinting Market, by Application,

10.1.1. Research Applications

10.1.1.1. Market Revenue and Forecast

10.1.2. Clinical Applications

10.1.2.1. Market Revenue and Forecast

Chapter 11. Global 3D Bioprinting Market, By End User 

11.1. 3D Bioprinting Market, by End User,

11.1.1. Research Organizations and Academic Institutes

11.1.1.1. Market Revenue and Forecast

11.1.2. Biopharmaceutical companies

11.1.2.1. Market Revenue and Forecast

11.1.3. Hospitals

11.1.3.1. Market Revenue and Forecast

Chapter 12. Global 3D Bioprinting Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Component

12.1.2. Market Revenue and Forecast, by Technology

12.1.3. Market Revenue and Forecast, by Application

12.1.4. Market Revenue and Forecast, by End User

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Component

12.1.5.2. Market Revenue and Forecast, by Technology

12.1.5.3. Market Revenue and Forecast, by Application

12.1.5.4. Market Revenue and Forecast, by End User

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Component

12.1.6.2. Market Revenue and Forecast, by Technology

12.1.6.3. Market Revenue and Forecast, by Application

12.1.6.4. Market Revenue and Forecast, by End User

12.2. Europe

12.2.1. Market Revenue and Forecast, by Component

12.2.2. Market Revenue and Forecast, by Technology

12.2.3. Market Revenue and Forecast, by Application

12.2.4. Market Revenue and Forecast, by End User

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Component

12.2.5.2. Market Revenue and Forecast, by Technology

12.2.5.3. Market Revenue and Forecast, by Application

12.2.5.4. Market Revenue and Forecast, by End User

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Component

12.2.6.2. Market Revenue and Forecast, by Technology

12.2.6.3. Market Revenue and Forecast, by Application

12.2.6.4. Market Revenue and Forecast, by End User

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Component

12.2.7.2. Market Revenue and Forecast, by Technology

12.2.7.3. Market Revenue and Forecast, by Application

12.2.7.4. Market Revenue and Forecast, by End User

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Component

12.2.8.2. Market Revenue and Forecast, by Technology

12.2.8.3. Market Revenue and Forecast, by Application

12.2.8.4. Market Revenue and Forecast, by End User

12.3. APAC

12.3.1. Market Revenue and Forecast, by Component

12.3.2. Market Revenue and Forecast, by Technology

12.3.3. Market Revenue and Forecast, by Application

12.3.4. Market Revenue and Forecast, by End User

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Component

12.3.5.2. Market Revenue and Forecast, by Technology

12.3.5.3. Market Revenue and Forecast, by Application

12.3.5.4. Market Revenue and Forecast, by End User

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Component

12.3.6.2. Market Revenue and Forecast, by Technology

12.3.6.3. Market Revenue and Forecast, by Application

12.3.6.4. Market Revenue and Forecast, by End User

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Component

12.3.7.2. Market Revenue and Forecast, by Technology

12.3.7.3. Market Revenue and Forecast, by Application

12.3.7.4. Market Revenue and Forecast, by End User

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Component

12.3.8.2. Market Revenue and Forecast, by Technology

12.3.8.3. Market Revenue and Forecast, by Application

12.3.8.4. Market Revenue and Forecast, by End User

12.4. MEA

12.4.1. Market Revenue and Forecast, by Component

12.4.2. Market Revenue and Forecast, by Technology

12.4.3. Market Revenue and Forecast, by Application

12.4.4. Market Revenue and Forecast, by End User

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Component

12.4.5.2. Market Revenue and Forecast, by Technology

12.4.5.3. Market Revenue and Forecast, by Application

12.4.5.4. Market Revenue and Forecast, by End User

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Component

12.4.6.2. Market Revenue and Forecast, by Technology

12.4.6.3. Market Revenue and Forecast, by Application

12.4.6.4. Market Revenue and Forecast, by End User

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Component

12.4.7.2. Market Revenue and Forecast, by Technology

12.4.7.3. Market Revenue and Forecast, by Application

12.4.7.4. Market Revenue and Forecast, by End User

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Component

12.4.8.2. Market Revenue and Forecast, by Technology

12.4.8.3. Market Revenue and Forecast, by Application

12.4.8.4. Market Revenue and Forecast, by End User

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Component

12.5.2. Market Revenue and Forecast, by Technology

12.5.3. Market Revenue and Forecast, by Application

12.5.4. Market Revenue and Forecast, by End User

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Component

12.5.5.2. Market Revenue and Forecast, by Technology

12.5.5.3. Market Revenue and Forecast, by Application

12.5.5.4. Market Revenue and Forecast, by End User

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Component

12.5.6.2. Market Revenue and Forecast, by Technology

12.5.6.3. Market Revenue and Forecast, by Application

12.5.6.4. Market Revenue and Forecast, by End User

Chapter 13. Company Profiles

13.1. 3D Bioprinting Solutions

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Advanced Solutions Life Sciences, LLC

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Allevi Inc.

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Aspect Biosystems Ltd.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Bico group ab

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Bio3D Technologies Pte. Ltd.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Cellink Global

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Collplant Biotechnologies Ltd.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Cyfuse Biomedical K.K.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Electro Optical Systems

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global 3D bioprinting market size was accounted at USD 3 billion in 2024 and it is projected to hit around USD 13.05 billion by 2034.

The global 3D bioprinting market is poised to grow at a CAGR of 15.84% from 2025 to 2034.

The major players operating in the 3D bioprinting market are 3D Bioprinting Solutions, Advanced Solutions Life Sciences, LLC, Allevi Inc., Aspect Biosystems Ltd., Bico group ab, Bio3D Technologies Pte. Ltd., Cellink Global, Collplant Biotechnologies Ltd., Cyfuse Biomedical K.K., Electro Optical Systems, EnvisionTEC, Inc., Foldink Life Science Technologies, Formlabs, Inc., GE Healthcare, Inventia Life Science PTY LTD, Optomec Inc., Organovo Holdings Inc, Pandorum Technologies pvt. ltd., Poietis, Precise Bio, Regenovo Biotechnology Co. Ltd., Renishaw plc., Revotek co., ltd., Rokit Healthcare, inc., Stratasys Ltd., Vivax Bio, LLC

Being used more and more in the cosmetics and pharmaceutical industries is the primary driving factors of the 3D bioprinting market.

North America region will lead the global 3D bioprinting market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client